Release Date: December 5, 2012
The Bridging Interventional Development Gaps program (BrIDGs) makes available, on a competitive basis, certain critical resources needed for the development of new therapeutic agents. This is not a grant program. Instead, successful applicants receive access to NIH contractors who conduct preclinical studies at no cost to the investigator. In general, synthesis, formulation, pharmacokinetic and toxicology resources are available to support investigator-held Investigational New Drug (IND) applications to the U.S. Food and Drug Administration.
Access to these contracts is based upon a peer-reviewed application process. The number of awards made will depend on the number of applications received, their scientific merit, and the availability of NIH funds. Contract costs are supported by the NIH Common Fund and collaborating NIH Institutes and Centers. BrIDGs is administered by the Division of Preclinical Innovation within the National Center for Advancing Translational Sciences.
Applications are accepted once per year. The next submission deadline for applications to the BrIDGs program will occur on February 1, 2013. Final decisions are expected to be made by September 2013.
Potential therapies for any disease or disorder may be submitted to BrIDGs. All proposed therapeutic agents should have demonstrated pharmacological activity in an appropriate in vivo disease model before applying.
Applications are accepted for the development of the following therapeutic agents:
Available services include:
The following organizations are eligible to apply:
Applications may be submitted electronically through the proposalCENTRAL application system between December 1, 2012 and February 1, 2013. Details on the application content and format can be found in the "how to apply" section of the BrIDGs website.
Please direct all inquiries to:
National Center for Advancing Translational Sciences
6701 Democracy Blvd, Room 929
Bethesda, MD 20817
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.